These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 22166172

  • 1. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L, Correll CU.
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C.
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [Abstract] [Full Text] [Related]

  • 3. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW.
    CNS Drugs; 2005 Aug; 19 Suppl 1():1-93. PubMed ID: 15998156
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.
    Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C.
    J Clin Psychopharmacol; 2012 Jun; 32(3):309-16. PubMed ID: 22544019
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A, de Haan L.
    Psychopharmacol Bull; 2010 Jun; 43(3):45-81. PubMed ID: 21150846
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C.
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [Abstract] [Full Text] [Related]

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Mar; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 9. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
    Hasnain M, Vieweg WV, Hollett B.
    Postgrad Med; 2012 Jul; 124(4):154-67. PubMed ID: 22913904
    [Abstract] [Full Text] [Related]

  • 10. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
    Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK.
    JAMA; 2009 Oct 28; 302(16):1765-73. PubMed ID: 19861668
    [Abstract] [Full Text] [Related]

  • 11. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
    Correll CU.
    J Clin Psychiatry; 2008 Oct 28; 69 Suppl 4():26-36. PubMed ID: 18533766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T, Kin NM, Beaulieu S, de Baptista EA.
    Pharmacopsychiatry; 2002 Nov 28; 35(6):205-19. PubMed ID: 12518268
    [Abstract] [Full Text] [Related]

  • 14. Hyperglycemia and antipsychotic medications.
    Haupt DW, Newcomer JW.
    J Clin Psychiatry; 2001 Nov 28; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Ozlen N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1434-8. PubMed ID: 18579280
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.